Scholars Central

Conference abstractPublished 8 Apr 2013

Investigation into the mechanism of action of B cell antagonists through a targeted metabolomics approach

Authors: Sarah Gentry, Alla Kloss, Paul Mason, Aharon Cohen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bcells are known to play a critical role in many disease settings such as multiple sclerosis, transplant rejection and immune mediated diseases. A phenotypic screen was undertaken to identify inhibitors of proliferation of primary human B cells. This screen yielded multiple chemical series; however, in each case, the mechanism of action/molecular efficacy target was unknown. For one key series emerging from this effort, preliminary physical data indicated that deoxycytidine kinase (dCK) interacted with this scaffold, and could be the efficacy target. The application of our targeted metabolic analysis methodology, however, showed a spectrum of changes inconsistent with dCK inhibition. This provided critical evidence that dCK was not the molecular target of the chemical series, and allowed re-focusing of target identification efforts beyond dCK.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Metabolomics:Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMetabolomics:Open Access
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Sarah Gentry”
  • BylineArticles whose byline prints “Alla Kloss”
  • BylineArticles whose byline prints “Paul Mason”
  • BylineArticles whose byline prints “Aharon Cohen”